← Back to Clinical Trials
Recruiting NCT07535060

NCT07535060 Pontic Site Development With or Without Fixed Partial Denture

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07535060
Status Recruiting
Phase
Sponsor Cairo University
Condition Mucogingival Defects
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-10-06
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Connective Tissue Graft (CTG)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-10-06 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effectiveness of soft tissue augmentation using connective tissue graft (CTG) in pontic site defects. It compares clinical and volumetric outcomes between sites with an existing fixed partial denture (FDP) and sites without an FDP. Following tooth extraction, alveolar ridge resorption often leads to soft tissue defects that can compromise esthetics, function, and prosthetic outcomes. CTG is considered the gold standard for soft tissue augmentation due to its predictable improvement in tissue thickness and stability. In this non-randomized clinical trial, patients with single edentulous sites in the esthetic zone will undergo CTG using a standardized surgical technique. The primary outcome is keratinized tissue thickness, while secondary outcomes include keratinized tissue width, volumetric soft tissue changes, esthetic evaluation (Pink Esthetic Score), plaque index, post-operative pain, and patient satisfaction. Clinical and digital assessments will be conducted preoperatively and at follow-up intervals up to 6 months. The study aims to determine whether performing CTG around an existing bridge provides comparable or improved outcomes compared to sites without a bridge, potentially offering a less invasive alternative to prosthetic replacement.

Eligibility Criteria

Inclusion Criteria: * Patients will on missing tooth in the esthetic zone (2nd premolar to 2nd premolar), missing at least 3 months prior to recruitment, with or without FPD * Systemically free patient * ≥18 years of age * Intact gingival tissue with at least 2mm keratinized tissue in adjacent teeth * Patients accept to provide informed consent Exclusion Criteria: * Smokers. * Pregnancy and lactation * Periodontitis * Severe gagging reflex * Handicapped and mentally challenged patients * Active soft tissue infection

Contact & Investigator

Central Contact

Ahmed Mohamed Elatreby, BDs

✉ ahmed.elatreby@dentistry.cu.edu.eg

📞 01004177718

Principal Investigator

Enji Ahmed Mahmoud, PHD holder

STUDY DIRECTOR

Professor of Oral Medicine and Periodontology - Faculty of Dentistry, Cairo University.

Frequently Asked Questions

Who can join the NCT07535060 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Mucogingival Defects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07535060 currently recruiting?

Yes, NCT07535060 is actively recruiting participants. Contact the research team at ahmed.elatreby@dentistry.cu.edu.eg for enrollment information.

Where is the NCT07535060 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07535060 clinical trial?

NCT07535060 is sponsored by Cairo University. The principal investigator is Enji Ahmed Mahmoud, PHD holder at Professor of Oral Medicine and Periodontology - Faculty of Dentistry, Cairo University.. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology